Nasus Pharma Ltd. (NSRX)

Overview

Nasus Pharma is a pioneering clinical-stage specialty pharmaceutical company that is dedicated to the advancement of innovative intranasal medications aimed at treating critical medical situations. The company's focus is targeted primarily at severe allergic reactions, anaphylaxis, and opioid overdoses. With a commitment to enhancing patient outcomes, Nasus Pharma is developing a suite of products designed to provide immediate relief during emergencies. Leveraging a cutting-edge powder-based intranasal technology, they ensure rapid absorption of the drugs, which is vital in life-threatening scenarios.

Products and Services

• NS002 - Intranasal Powder Epinephrine Nasal Spray

  This product is an intranasal formulation of epinephrine specifically developed to be used in cases of type 1 severe allergies and anaphylaxis. The spray is easy to administer, allowing for rapid delivery of medication that can counteract the severe physiological reactions associated with allergic responses and potentially save lives during critical moments.

• NS001 - Intranasal Naloxone Powder Spray

  NS001 is aimed at addressing opioid overdose situations. This intranasal naloxone powder spray provides swift administration of naloxone, an opioid antagonist that can reverse the effects of opioid overdose. Its innovative powder formulation not only enhances stability and absorption but also ensures that individuals can receive timely intervention, which is crucial in saving lives in opioid-related emergencies.